24-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1141 9 470 76 925 166 1011
ERLYTX 77 2 104 5 61 12 73
GI 167 4 209 11 134 21 128
GU 362 9 470 40 487 75 457
LEUK 168 3 157 14 170 29 177
LUNG 208 1 52 18 219 38 231
LYMPH 430 8 417 36 438 68 414
MELAN 14 0 0 0 0 4 24
MMYEL 114 2 104 9 110 19 116
MULT 50 0 0 1 12 6 37
OTHER 54 1 52 2 24 5 30
Total 2785 39 2035 212 2580 443 2698

24-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 192 3 157 15 183 39 237
ERLYTX 4 0 0 0 0 1 6
GI 1 0 0 1 12 1 6
GU 6 0 0 0 0 1 6
LEUK 613 11 574 50 609 99 603
LUNG 376 7 365 25 304 58 353
OTHER 13 1 52 4 49 5 30
PEOLC 86 0 0 1 12 5 30
PREV 237 1 52 11 134 24 146
SXQOL 653 8 417 46 560 110 670
Total 2181 31 1617 153 1863 343 2087

24-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1141 9 470 76 925 166 1011
CCD 192 3 157 15 183 39 237
ERLYTX 81 2 104 5 61 13 79
GI 168 4 209 12 146 22 134
GU 368 9 470 40 487 76 463
LEUK 781 14 730 64 779 128 779
LUNG 584 8 417 43 524 96 584
LYMPH 430 8 417 36 438 68 414
MELAN 14 0 0 0 0 4 24
MMYEL 114 2 104 9 110 19 116
MULT 50 0 0 1 12 6 37
OTHER 67 2 104 6 73 10 61
PEOLC 86 0 0 1 12 5 30
PREV 237 1 52 11 134 24 146
SXQOL 653 8 417 46 560 110 670
Total 4966 70 3651 365 4444 786 4785

24-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 705 6 313 38 463 95 578
ERLYTX 53 2 104 4 49 10 61
GI 128 4 209 11 134 19 116
GU 272 4 209 25 304 50 304
LEUK 105 1 52 9 110 18 110
LUNG 131 1 52 13 158 24 146
LYMPH 281 6 313 23 280 44 268
MELAN 12 0 0 0 0 4 24
MMYEL 64 1 52 5 61 13 79
MULT 19 0 0 0 0 3 18
OTHER 54 1 52 2 24 5 30
Total 1824 26 1356 130 1583 285 1734

24-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 140 1 52 7 85 22 134
ERLYTX 4 0 0 0 0 1 6
GI 1 0 0 1 12 1 6
GU 6 0 0 0 0 1 6
LEUK 253 3 157 20 244 39 237
LUNG 225 4 209 16 195 38 231
OTHER 13 1 52 4 49 5 30
PEOLC 69 0 0 1 12 5 30
PREV 237 1 52 11 134 24 146
SXQOL 482 8 417 39 475 85 517
Total 1430 18 939 99 1206 221 1343

24-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 890 14 730 57 694 130 791
CCD 166 1 52 10 122 20 122
ERLYTX 57 2 104 4 49 11 67
GI 135 4 209 13 158 22 134
GU 319 8 417 35 426 64 390
LEUK 361 4 209 31 377 59 359
LUNG 379 5 261 28 341 66 402
LYMPH 281 6 313 23 280 44 268
MELAN 12 0 0 0 0 4 24
MMYEL 64 1 52 5 61 13 79
MULT 42 0 0 5 61 6 37
OTHER 148 2 104 6 73 11 67
PEOLC 69 0 0 1 12 5 30
PREV 237 1 52 11 134 24 146
SXQOL 482 8 417 39 475 85 517
Total 3642 56 2920 268 3263 564 3433

24-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 971 9 470 71 864 154 937
ERLYTX 72 2 104 5 61 12 73
GI 98 3 157 7 85 11 67
GU 258 7 365 32 390 58 353
LEUK 136 2 104 12 146 25 152
LUNG 182 1 52 16 195 33 201
LYMPH 352 7 365 24 292 50 304
MMYEL 100 2 104 8 97 16 97
MULT 50 0 0 1 12 6 37
Total 2219 33 1721 176 2142 365 2221

24-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1910 26 1357 138 1680 291 1771
AFFIL 133 1 52 4 49 11 67
CCOP/NCORP 1211 17 887 87 1059 204 1242
Non-SWOG 1709 23 1200 133 1619 277 1686
Total 4963 67 3496 362 4407 783 4766

24-AUG-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
BREAST S2511 Brst, de novo StgIV oligo, locoreg tx vs SOC 1 Y 18-AUG-26
BREAST S2511 Brst, de novo StgIV oligo, locoreg tx vs SOC 2 Y 18-AUG-26
LYMPH S2506 NHL, R/R MZL, Mozun +/- Zanu or Pola 1 Y 18-AUG-26
LUNG S1900N AGAs: SG alone, I alone, or SG + I 1 Y 03-AUG-26

24-AUG-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
CCD S1703 Met Breast, STM-monitoring v Usual Care 1 N 15-AUG-26
LUNG A082002 Lung, Adv, Systemic Tx +/- SBRT 1 E 14-AUG-26
GI NRGGI006 Esophagus, Stg I-IVA, PBT vs IMRT 1 E 07-AUG-26
GI NRGGI006 Esophagus, Stg I-IVA, PBT vs IMRT 2 E 07-AUG-26
LUNG S2402 NSCLC, All Stg, Periop Vs Adj Tx 1 E 07-AUG-26
SXQOL NRGCC011 Breast, Survivors, Cog Training 0 E 03-AUG-26
SXQOL NRGCC011 Breast, Survivors, Cog Training 1 E 03-AUG-26

24-AUG-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 11
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 8
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 8
LUNG LUNGMAP NSCLC, Adv, Master 1 7
LUNG LUNGMAP NSCLC, Adv, Master 2 6
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 6
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 5
BREAST NRGBR009 Breast, EarlyStg, Adjuvant Chemo 1 3
GU S2312 Pros, MCRPC, Cab +/- Carb 1 3
GU S2419 Renal, adv clear cell, IO +/- Biotx, BIOFRONT 1 3